Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: further explanation of a dose-escalating pilot study conducted primarily to consider the safety of this pharmacological modification.
作者信息
Curnow A, Campbell S M
出版信息
Br J Dermatol. 2010 Jan;162(1):224-5. doi: 10.1111/j.1365-2133.2009.09544.x. Epub 2009 Nov 9.
Abstract
摘要
相似文献
1
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: further explanation of a dose-escalating pilot study conducted primarily to consider the safety of this pharmacological modification.
Br J Dermatol. 2010 Jan;162(1):224-5. doi: 10.1111/j.1365-2133.2009.09544.x. Epub 2009 Nov 9.
2
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma: when statistics make a difference.
Br J Dermatol. 2009 Jul;161(1):215-6. doi: 10.1111/j.1365-2133.2009.09232.x. Epub 2009 May 12.
3
Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Br J Dermatol. 2008 Aug;159(2):387-93. doi: 10.1111/j.1365-2133.2008.08668.x. Epub 2008 Jun 9.
4
Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma.
J Cancer Res Clin Oncol. 2008 Aug;134(8):841-9. doi: 10.1007/s00432-008-0358-6. Epub 2008 Feb 1.
5
Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light.
Arch Dermatol. 1997 Dec;133(12):1494-5.
6
Rapid progression of a basal cell carcinoma after photodynamic therapy.
Dermatol Surg. 2010 Aug;36(8):1328-31. doi: 10.1111/j.1524-4725.2010.01633.x. Epub 2010 Jun 24.
7
Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid.
Lasers Surg Med. 2006 Apr;38(4):325-31. doi: 10.1002/lsm.20328.
8
A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma.
Lasers Surg Med. 2006 Jun;38(5):417-26. doi: 10.1002/lsm.20363.
9
Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
J Drugs Dermatol. 2006 Jul-Aug;5(7):642-5.
10
Topical applications of iron chelators in photosensitization.
Photochem Photobiol Sci. 2007 Dec;6(12):1268-74. doi: 10.1039/b703861e. Epub 2007 Sep 11.
引用本文的文献
1
[Localized scleroderma (morphea) in childhood].
Hautarzt. 2012 Feb;63(2):89-96. doi: 10.1007/s00105-011-2199-5.
Zotero 插件